CollPlant Biotechnologies Ltd. (CLGN)

CollPlant Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	35	41	73	93	175	71
Market Cap Growth	-51.77%	-43.65%	-21.52%	-46.69%	147.09%	129.10%
Enterprise Value	29	29	47	63	132	69
Last Close Price	2.88	3.60	6.39	8.35	16.36	10.77
PE Ratio	-	-	-	-	738.04	-
Forward PE	-	-	-	12.02	17.40	-
PS Ratio	13.35	80.07	6.68	311.88	11.18	11.54
PB Ratio	2.66	3.06	2.58	2.89	3.88	15.81
P/TBV Ratio	2.98	3.09	2.60	2.91	3.90	16.11
P/FCF Ratio	-	-	-	-	163.01	-
P/OCF Ratio	-	-	-	-	69.94	-
EV/Sales Ratio	11.62	56.54	4.32	211.86	8.47	11.25
EV/EBITDA Ratio	-	-	-	-	157.99	-
EV/EBIT Ratio	-	-	-	-	2036.83	-
EV/FCF Ratio	-	-	-	-	123.39	-
Debt / Equity Ratio	0.23	0.23	0.11	0.09	0.08	0.76
Debt / EBITDA Ratio	-	-	-	-	2.43	-
Debt / FCF Ratio	-	-	-	-	3.36	-
Asset Turnover	0.10	0.02	0.31	0.01	0.50	0.57
Inventory Turnover	1.92	2.82	1.86	0.32	1.71	2.79
Quick Ratio	4.14	4.21	8.33	9.73	14.60	1.30
Current Ratio	4.48	4.44	8.62	10.20	14.96	1.68
Return on Equity (ROE)	-75.27%	-79.46%	-23.16%	-43.73%	0.96%	-134.83%
Return on Assets (ROA)	-38.34%	-40.81%	-13.06%	-24.02%	0.13%	-32.41%
Return on Capital (ROIC)	-42.65%	-44.88%	-14.08%	-25.47%	0.14%	-44.95%
Return on Capital Employed (ROCE)	-	-	-	-	0.10%	-
Earnings Yield	-37.86%	-40.28%	-9.59%	-18.15%	0.14%	-8.16%
FCF Yield	-33.91%	-35.35%	-5.08%	-16.05%	0.61%	-6.91%
Buyback Yield / Dilution	-0.17%	-0.57%	-3.23%	7.80%	-73.76%	-38.12%

Updated May 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q